Arkolith/Insider Trading/ZIVO/Form 4

Payne John Bernard

President and CEO, DirectorZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Jan 28, 2026
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2026Buy(P)12K$8.54$100K20K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-26-000651) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML